Health ❯ Pharmaceuticals

Drug Safety

Contaminated Drugs Contaminated Products Quality Control Contamination Adulteration Toxicology Adverse Effects Regulatory Actions FDA Regulations Recalls Toxic Substances Regulatory Compliance Mifepristone Acetaminophen Regulations Regulation Cough Syrups Fentanyl Contaminants Counterfeit Drugs Contaminated Medications Side Effects Clinical Trials Legal Issues Counterfeit Medications Manufacturing Practices GLP-1 Drugs Abortion Pills Abortion Drugs Regulatory Issues Cough Syrup Adulterated Products Hormonal Therapies Health Risks Drug Recalls Adverse Events Product Recalls Contamination Issues Pregnancy Risks Pregnancy Health Acetaminophen Risks Mental Health Carcinogens Cancer Risks Cancer Risk Prenatal Health FDA Approval Contaminated Medicines Regulatory Affairs Contraceptives Consumer Protection Ranitidine Covid-19 Treatments Licensing Regulations Contaminated Pharmaceuticals Pregnancy Abortifacient Drugs Overdose Risks Lawsuits Regulatory Agencies Paracetamol Vaccine Ingredients Medication Side Effects Pharmacovigilance Opioids Antidepressants Contaminated Substances Advertising Practices Medication Review Compounded Drugs Adulterated Drugs Accountability Psychiatric Side Effects Addiction Pregnancy Medications Medical Negligence Paediatric Medicine Regulatory Bodies Weight Loss Drugs Potency Drugs Regulatory Alerts Expired Drugs Litigation Quality Assurance Sodium Valproate Chirality in Drugs Manufacturing Inspections Illicit Drugs Toxicity Manufacturing Standards Diethylstilbestrol Consumer Health Products Adverse Drug Reactions Prescription Medications Medication Traceability Consumer Warnings Diethylstilbestrol (DES) Medication Recall Counterfeit Medicines Drug Importation

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Access will remain limited without lower prices and more production, the WHO warns.

Appeals Court Weighs Revival of Tylenol–Autism Cases as Texas Judge Rejects Paxton’s Requests

Florida Sues Planned Parenthood Over ‘Safer Than Tylenol’ Abortion Pill Claim, Seeks $350 Million

Paxton Moves to Block Kenvue’s $400 Million Dividend, Seeks Curbs on Tylenol Ads

FDA Class II Recall Targets 580,000 Prazosin Bottles for Nitrosamine Overages

Texas Sues J&J and Kenvue Over Tylenol Marketing to Pregnant Women, Citing Autism Risk

FDA Lists Class II Recall of 141,984 Bottles of Generic Atorvastatin

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

India Cough Syrup Crisis: Sresan Pharma Owner Detained as Tamil Nadu Confirms Toxic Contamination

FDA Reviews Tylenol Label as WHO Rejects Claims of Prenatal Link to Autism

FDA Opens Mifepristone Safety Review as Republicans Move to Curb Mail and Telehealth Access

Eli Lilly Halts Diabetes Arm of Bimagrumab Obesity Trial Weeks After Launch

Kenvue Rebounds as White House Pushes Tylenol Label Changes Without New Evidence

Novo Nordisk Freezes Hiring as Layoffs Loom in GLP-1 Retrenchment

Over 100 Dead in Argentina from Bacteria-Contaminated Fentanyl Linked to HLB Pharma

Depo-Provera Study Finds 3.5-Times Higher Meningioma Risk as U.S. Suits Top 550

Missouri AG Files Suit Over Planned Parenthood’s Mifepristone Safety Claims

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

FDA Commissioner Pledges Safety Review of Abortion Pill Mifepristone